Research ArticleFibrosis

Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β

See allHide authors and affiliations

Science Translational Medicine  28 Jun 2017:
Vol. 9, Issue 396, eaal3694
DOI: 10.1126/scitranslmed.aal3694
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article